Natus Medical's Neurology Unit Wins 510(K), Health Canada Clearance for UltraPro S100 EMG System

By: Benzinga
Natus Medical's (NASDAQ: BABY ) Neurology Incorporated unit announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Health Canada clearance for its new electrodiagnostic system, the UltraPro S100 EMG System. The UltraPro S100 is an EMG/Nerve Conduction device for monitoring and testing electrophysiologic and electrodiagnostic
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.